[1] Gao Y, Wu D, Chen B, et al. Rare variants in novel candidate
genes associated with nonsyndromic patent ductus arteriosus
identified with whole-exome sequencing[J]. Front Genet,
2022, 13:921925.
[2] Ke ZP, Zhang GF, Guo YH, et al. A novel PRRX1 loss-offunction
variation contributing to familial atrial fibrillation and
congenital patent ductus arteriosus[J]. Genet Mol Biol, 2022,
45(2):e20210378.
[3] Abhinav P, Zhang GF, Zhao CM, et al. A novel KLF13
mutation underlying congenital patent ductus arteriosus and
ventricular septal defect, as well as bicuspid aortic valve[J].
Exp Ther Med, 2022, 23(4):311.
[4] Ma L, Wang J, Li L, et al. ISL1 loss-of-function mutation
contributes to congenital heart defects[J]. Heart Vessels, 2019,
34(4):658-668.
[5] Qiao XH, Wang F, Zhang XL, et al. MEF2C loss-of-function
mutation contributes to congenital heart defects[J]. Int J Med
Sci, 2017, 14(11):1143-1153.
[6] Shi HY, Xie MS, Yang CX, et al. Identification of SOX18
as a new gene predisposing to congenital heart disease[J].
Diagnostics, 2022, 12(8):1917.
[7] 乔祺, 杨晨曦, 顾佳宁, 等. KLF15基因突变导致心房颤动的
机制研究[J]. 国际心血管病杂志, 2021, 48(1):53-57.
[8] Lilly AJ, Lacaud G, Kouskoff V. SOXF transcription factors
in cardiovascular development[J]. Semin Cell Dev Biol, 2017,
63:50-57.
[9] Wangberg H, Wigby K, Jones MC. A novel autosomal
dominant mutation in SOX18 resulting in a fatal case of
hypotrichosis-lymphedema-telangiectasia syndrome[J]. Am J
Med Genet A, 2018, 176(12):2824-2828.
[10] Huang RT, Guo YH, Yang CX, et al. SOX7 loss-of-function
variation as a cause of familial congenital heart disease[J]. Am
J Transl Res, 2022, 14(3):1672-1684.
[11] Azuma T, Seki N, Yoshikawa T, et al. cDNA cloning, tissue
expression, and chromosome mapping of human homolog of
SOX18[J]. J Hum Genet, 2000, 45(3):192-195.
[12] Swift MR, Pham VN, Castranova D, et al. SoxF factors
and Notch regulate nr2f2 gene expression during venous
differentiation in zebrafish[J]. Dev Biol, 2014, 390(2):116-
125.
[13] Hosking BM, Wang SC, Chen SL, et al. SOX18 directly
interacts with MEF2C in endothelial cells[J]. Biochem
Biophys Res Commun, 2001, 287(2):493-500.
[14] Peng T, Wang L, Zhou SF, et al. Mutations of the GATA4 and
NKX2.5 genes in Chinese pediatric patients with non-familial
congenital heart disease[J]. Genetica, 2010, 138(11/12):1231-
1240.
[15] Sakamoto Y, Hara K, Kanai-Azuma M, et al. Redundant roles
of Sox17 and Sox18 in early cardiovascular development of
mouse embryos[J]. Biochem Biophys Res Commun, 2007,
360(3):539-544.
[16] Zhang C, Basta T, Klymkowsky MW. SOX7 and SOX18 are
essential for cardiogenesis in Xenopus[J]. Dev Dyn, 2005,
234(4):878-891.
[17] Zhao L, Jiang WF, Yang CX, et al. SOX17 loss-of-function
variation underlying familial congenital heart disease[J]. Eur J
Med Genet, 2021, 64(5):104211.
[18] Hu L, Chen L, Yang L, et al. KCTD1 mutants in scalpear-
nipple syndrome and AP-2α P59A in Char syndrome
reciprocally abrogate their interactions, but can regulate Wnt/
β-catenin signaling[J]. Mol Med Rep, 2020, 22(5):3895-3903.
[19] Coulie R, Niyazov DM, Gambello MJ, et al. Hypotrichosislymphedema-
telangiectasia syndrome: report of ileal atresia
associated with a SOX18 de novo pathogenic variant and
review of the phenotypic spectrum[J]. Am J Med Genet A,
2021, 185(7):2153-2159.